Top 10 Low Price Stocks To Own Right Now

Either low-income Americans became rich this Black Friday, or Wal-Mart’s (NYSE:WMT) marketers do not know what they are doing.

For years, $133,653 Cartier watches and expensive jewelry were sold in upper scale stores, where high income Americans prefer to shop on Black Friday. 

This year, Cartier watches are being sold on the Walmart.com site.

But who will buy them? Will high income Americans trade the upscale store for Wal-Mart’s site? That sounds very unlikely to me. Shopping for luxury items is usually more about the experience of shopping rather than about price.

What about Wal-Mart’s low-income shoppers? That’s unlikely, too, as they cannot afford items that sell at a hefty multiple of their annual income. Besides, some of Wal-Mart’s shoppers do not even use credit cards, so how can they purchase $133,653 watches on-line?

For more than three decades, Wal-Mart ruled the US retailing industry. Its large stores and everyday low prices were too much for smaller neighborhood stores and supermarkets. Result? They went out of business shortly after Wal-Mart invaded their turf.

Top 10 Low Price Stocks To Own Right Now: LKQ Corporation(LKQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Wednesday's regular session.

Top 10 Low Price Stocks To Own Right Now: Inovio Pharmaceuticals, Inc.(INO)

Advisors’ Opinion:

  • [By William Patalon III]

    In a Private Briefing report in late July, we told you that tiny biotech Inovio Pharmaceuticals Inc. (Nasdaq: INO) had dosed its first patient in a Phase I clinical study to evaluate its synthetic vaccine for the Zika virus.

  • [By Lisa Levin]

    Inovio Pharmaceuticals Inc (NASDAQ: INO) shares were also up, gaining 24 percent to $8.84 following announcement of a clinical study for a HIV vaccine that had nearly 100 percent immune response.

  • [By Ben Levisohn]

    Shares of Inovio Pharmaceuticals(INO) are climbing today after the biotech company announced that it would begin testing a Zika vaccine in Puerto Rico. Maxim’sJason McCarthy andJason Kolbert have the details:

    CREDIT: Alex Wild Published Credit: Alex Wild Alex Wild

    Inovio announced the initiation of a small clinical study (N=160) of its Zika vaccine, GLS-5700 (being developed with GeneOne Life Sciences), in Puerto Rico. It is estimated by the CDC that the Zika virus could infect more than 25% of the population of Puerto Rico by YE16.The study will evaluate safety, immunogenicity and early signs of efficacy in preventing Zika infection. Data are expected in 2017, and if positive, Inovio will discuss with regulators the best path forward.

    In addition, the phase I study of GLS-5700 (N=40) in the U.S. and Canada, which is the first in-human Zika vaccine study, is now fully enrolled. Data evaluating safety and immunogenicity are expected by YE16.

    Conclusion. With the Zika virus spreading, including to the U.S., there remains an urgent need for a vaccine. Inovio continues to demonstrate that the company’s DNA-based vaccine approach is safe and can rapidly transition to human studies.

    Shares of Inovio Pharmaceuticalshave gained 4.3% to $9.24 at 2:50 p.m. today, while the iShares Nasdaq Biotechnology ETF (IBB) has dipped 0.3% to $284.29.

Top 10 Low Price Stocks To Own Right Now: Merck & Company, Inc.(MRK)

Advisors’ Opinion:

  • [By Chris Lange]

    Merck & Co., Inc. (NYSE: MRK) is expected to share its latest quarterly earnings on Friday. The consensus estimates are$0.87 in EPS on $9.74 billion in revenue. Shares were at $62.63 at Fridays close, in a 52-week range of $57.18 to $66.80. The consensus price target is $69.70.

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) dropped about 6.6% Monday to post a new 52-week low of $54.41 after closing at $58.24 on Friday. The stock’s 52-week high is $66.80. Volume of around 32 million was about four times the daily average. The drug maker said it had withdrawn its application for approval of a key lung cancer treatment.

  • [By Ben Levisohn]

    Jefferies analyst Jeffrey Holford and aren’t feeling too upbeat about pharmaceutical stocks in 2017, noting that politics, as well as pharmacy benefit managers, could put downward pressure on pricing. Then there are the weakening fundamentals. As a result, they cut their rating Merck (MRK) to Underperform from Hold…

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Ben Levisohn]

    Short story is, growth products are slowing and large net price increases are appearing increasingly unsustainable, even if the government doesn’t intervene. The innovation cycle appears to be in a waning period and, so far, large-caps with boatloads of cash seem to be hesitant to act. 2017 should have some excitement. We may finally see a successful registrational study in Alzheimer’s disease (Axovant Sciences’ (AXON) intepirdine or Merck’s (MRK) verubecestat), CAR T will finally get to plead its case, and we may find out once and for all if those ‘transformational’ PCSK9s are just that…

  • [By Paul Ausick]

    Merck & Co. Inc. (NYSE: MRK) traded up 0.36% at $56.54. The stock’s 52-week range is $53.63 to $66.80. Volume was about 70% below the daily average of around 11.7 million shares. The company had no specific news.

Top 10 Low Price Stocks To Own Right Now: Energy Select Sector SPDR ETF (XLE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Yesterday, ExxonMobil (XOM) reported earnings that didn’t do much to excite investors, and today its shares are falling again, making my bearish call from Jan. 14 look better and better. Strategas Research Partners’ Chris Verrone and team note that Exxon–the largest stock in the Energy Select Sector SPDR ETF (XLE) with a 16% weighting–continues to weigh on the energy sector:

  • [By Ben Levisohn]

    Shares of ExxonMobil have advanced 0.8% to $81.89 at 2:02 p.m. today, while the Energy Select Sector SPDR ETF (XLE) has advanced 0.4% to $68.07.

     

  • [By Craig Jones]

    Joe Tigay spoke on Bloomberg Markets about his trading strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He said crude oil has been trading between $50 and $55 lately and every time it drops close to $50, domestic supply decreases and the price moves higher. He believes crude oil could move higher from its current price level and he wants to set up a bullish strategy. He wants to buy Energy Select Sector SPDR (ETF) shares and sell the April $73 call for $1.40.

  • [By ]

    When we compare the energy sectors recent run to the S&P 500, its not even close. The Energy Select Sector SPDR (NYSE:XLE) has jumped more than 20% since Sept. 1. The S&P is up a little more than 10% over the same timeframe.

  • [By Craig Jones]

    On CNBC's Trading Nation, Andrew Keene of AlphaShark suggested a bearish options strategy in Energy Select Sector SPDR (ETF) (NYSE: XLE).

    He noticed that Energy Select Sector SPDR (ETF) broke out above its resistance, but he thinks it's a fake breakout, which is not going to hold. Keene wants to use options to fade the rally. He wants to buy the March 70/67 put spread for $1. The trade breaks even at $69 or 5.19 percent lower and it can maximally make a profit of $2 if the stock drops to $67 or lower.

Top 10 Low Price Stocks To Own Right Now: Pretium Resources, Inc.(PVG)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    Pretium Resources (PVG) remains on target with its development of what will be a world-class gold mine in British Columbia. The Brucejack property is slated to begin commercial production in mid-2017.

Top 10 Low Price Stocks To Own Right Now: Albemarle Corporation(ALB)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    With an improving global economy, now is a great time to be a chemical company, Cramer told viewers, as he reiterated his favorites: Albemarle (ALB) and FMC Technology  (FMC) .

  • [By Beth McKenna]

    Most investors interested in gaining exposure to the lithium space should stick with investing in one or more of the large players listed on a major U.S. stock exchange:Albemarle Corporation(NYSE:ALB), FMC Corp. (NYSE:FMC), andSociedad Quimica y Minera de Chile(NYSE:SQM), or SQM. Smaller players are speculative to varying degrees, and most are unprofitable.

  • [By Ben Levisohn]

    Albemarle (ALB) soared to the top of the S&P 500 today after beating fourth-quarter earnings and revenue forecasts.

    S. MARTIN/AFP/Getty Images

    Albemarle gained 9.8% to $101.50, while the S&P 500 dipped 0.3% to 2,363.64.

    Baird’s Ben Kallo and team liked what they saw from Albemarle:

    Reiterate Outperform rating after results beat and guidance exceeded estimates. ALB continues to see strong Lithium demand and pricing, expects Refining Solutions to return to earnings growth in 2017 driven by stronger HPC demand, and bolstered its balance sheet with the sale of Surface Treatment. Additionally, although Bromine is expected to be flat y/y, the segment should generate strong FCF for Lithium investment. We expect shares to trade higher as ALB continues to separate itself from specialty chemical comps with leading market positions and strong revenue growth.

    Albemarle’s market capitalization rose to $11.4 billion today from $10.4 billion yesterday.

  • [By Zacks]

    Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
     
    Albemarle Corporation (NYSE: ALB): Free Stock Analysis Report
     
    Celanese Corporation (NYSE: CE): Free Stock Analysis Report
     
    Kronos Worldwide Inc (NYSE: KRO): Free Stock Analysis Report
     
    Koppers Holdings Inc. (NYSE: KOP): Free Stock Analysis Report
     
    Chemours Company (The) (CC): Free Stock Analysis Report
     
    Kraton Corporation (NYSE: KRA): Free Stock Analysis Report
     
    To read this article on Zacks.com click here.
     
    Zacks Investment Research

Top 10 Low Price Stocks To Own Right Now: Wabash National Corporation(WNC)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of Wabash National Corporation (NYSE:WNC) jumped 10.1% in April, according to data provided by S&P Global Market Intelligence, after the company reported its first-quarter 2017 results.

Top 10 Low Price Stocks To Own Right Now: Jabil Circuit Inc.(JBL)

Advisors’ Opinion:

  • [By Monica Gerson]

    Analysts expect Jabil Circuit, Inc. (NYSE: JBL) to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion. Jabil Circuit shares fell 0.83 percent to close at $21.42 yesterday.

  • [By Monica Gerson]

    Jabil Circuit, Inc. (NYSE: JBL) is projected to post its quarterly earnings at $0.60 per share on revenue of $4.50 billion.

    Guess?, Inc. (NYSE: GES) is expected to post its quarterly earnings at $0.58 per share on revenue of $657.59 million.

  • [By Chris Lange]

    And Jabil Inc. (NYSE: JBL) will report its fiscal first-quarter results on Thursday. The consensus estimates are EPS of $0.79 and revenue of $5.5 billion. Shares traded at $27.88 on Friday’s close, in a 52-week range of $21.31 to $31.70. The consensus price target is $32.23.

Top 10 Low Price Stocks To Own Right Now: Meritage Corporation(MTH)

Advisors’ Opinion:

  • [By Jason Hall]

    WhenMeritage Homes Corp(NYSE:MTH) last reported earnings to wrap up fiscal 2016, it left investors with reason to be concerned. The company finished the year with strong 15% home-closing revenue growth in the fourth quarter, 19% home-closing revenue growth for the full year, and a 15% jump in earnings per share for the year. Unfortunately, the homebuilder reported that its unit sales, and that its backlog of homes on order, were down from the year-ago period in the fourth quarter — not a positive metric considering the general strength of the new homes market and the company’s success in expanding and growing in recent years.

Top 10 Low Price Stocks To Own Right Now: Unilife Corporation(UNIS)

Advisors’ Opinion:

  • [By Lisa Levin]

    Unilife Corp (NASDAQ: UNIS) shares dropped 76 percent to $0.295. Unilife reduced its workforce by 51 employees and expects to record charge of $0.6 million.

Leave a Reply

Your email address will not be published. Required fields are marked *